Lantheus Holdings Inc (LNTH)
75.53
-2.65
(-3.39%)
USD |
NASDAQ |
May 03, 16:00
75.76
+0.23
(+0.30%)
After-Hours: 20:00
Lantheus Holdings Cash from Financing (Quarterly): -16.84M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -16.84M |
| December 31, 2023 | -0.45M |
| September 30, 2023 | 0.108M |
| June 30, 2023 | -4.051M |
| March 31, 2023 | -8.669M |
| December 31, 2022 | 317.84M |
| September 30, 2022 | -1.959M |
| June 30, 2022 | -2.011M |
| March 31, 2022 | -2.179M |
| December 31, 2021 | -2.10M |
| September 30, 2021 | -1.726M |
| June 30, 2021 | -0.715M |
| March 31, 2021 | -34.79M |
| December 31, 2020 | -4.373M |
| September 30, 2020 | -7.27M |
| June 30, 2020 | -6.486M |
| March 31, 2020 | -3.732M |
| December 31, 2019 | -2.823M |
| September 30, 2019 | -1.90M |
| June 30, 2019 | -72.93M |
| March 31, 2019 | -1.231M |
| December 31, 2018 | -0.934M |
| September 30, 2018 | -1.217M |
| Date | Value |
|---|---|
| June 30, 2018 | -1.813M |
| March 31, 2018 | -0.704M |
| December 31, 2017 | 1.15M |
| September 30, 2017 | -1.519M |
| June 30, 2017 | -1.827M |
| March 31, 2017 | -11.25M |
| December 31, 2016 | -12.26M |
| September 30, 2016 | -16.09M |
| June 30, 2016 | -0.928M |
| March 31, 2016 | -0.944M |
| December 31, 2015 | -1.042M |
| September 30, 2015 | -3.014M |
| June 30, 2015 | 5.514M |
| March 31, 2015 | -0.459M |
| December 31, 2014 | -0.361M |
| September 30, 2014 | -7.33M |
| June 30, 2014 | 5.399M |
| March 31, 2014 | -0.005M |
| December 31, 2013 | -0.197M |
| September 30, 2013 | -1.495M |
| June 30, 2013 | 7.948M |
| March 31, 2013 | -0.644M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-72.93M
Minimum
Jun 2019
317.84M
Maximum
Dec 2022
7.147M
Average
-2.501M
Median
Cash from Financing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 0.352M |
| Boston Scientific Corp | 1.569B |
| Align Technology Inc | -11.72M |
| Edwards Lifesciences Corp | 61.70M |
| NeuroMetrix Inc | 1.624M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 127.24M |
| Cash from Investing (Quarterly) | -106.53M |
| Free Cash Flow | 278.34M |
| Free Cash Flow Per Share (Quarterly) | 1.697 |
| Free Cash Flow to Equity (Quarterly) | 118.26M |
| Free Cash Flow to Firm (Quarterly) | 118.96M |
| Free Cash Flow Yield | 5.24% |